1. AF.81 NONINVASIVE ASSESSMENTS TO IDENTIFY PATIENTS WITH ADVANCED FIBROSIS DUE TO NASH: SCREENED POPULATION FROM THE REGENERATE TRIAL. (September 2021) Authors: Petta, S.; Boursier, J.; Sanyal, A.J.; Ratziu, V.; Rinella, M.; Loomba, R.; Dufour, J.; Granston, T.; Zhou, H.; Trylesinski, A.; Harrison, S.A.; Bedossa, P.; Goodman, Z.; Younossi, Z.; Noureddin, M.; Bugianesi, E.; Anstee, Q.M. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Algorithms using noninvasive tests can accurately identify patients with advanced fibrosis due to NASH: data from the STELLAR clinical trials. (February 2019) Authors: Lampertico, P.; Younossi, Z.M.; Lawitz, E.J.; Alkhouri, N.; Wong, V. Wai-Sun; Romero-Gomez, M.; Okanoue, T.; Trauner, M.; Kersey, K.; Li, G.; Subramanian, G.M.; Myers, R.P.; Djedjos, C.S.; Han, L.; Chen, G.; Nguyen, T.; Kohli, A.; Bzowej, N.; Younes, Z.; Sarin, S. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Commentary: phlebotomy in non‐alcoholic fatty liver disease. Issue 11 (9th May 2013) Authors: Garg, R.; Goodman, Z.; Younossi, Z. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 11(2013) Page Start: 1112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 Regenerate study. (February 2020) Authors: Anstee, Q.M.; Harrison, S.; Sanyal, Arun J.; Ratziu, V.; Rinella, M.; Younossi, Z.Y.; Boursier, J.; Francque, S.; Geerts, A.; Petta, S.; Bugianesi, E-; Romero-Gomez, M.; Schattenberg, J.M.; Sarkar, S.; Bonacini, M.; Yataco, M.; Porayko, M.; Siddique, A.; Dufour, J.; Ferro, T. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Obeticholic acid demonstrates sustained improvements at month 24 in transaminases and non-invasive markers of fibrosis: Results of a post hoc analysis from the interim analysis of the REGENERATE study. (March 2021) Authors: Loomba, R.; Ratziu, V.; Anstee, Q.M.; Harrison, S.; Sanyal, A.J.; Rinella, M.; Younossi, Z.Y.; Goodman, Z.; Bedossa, P.; Shringarpure, R.; Zhou, H.; Noureddin, M.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Obeticholic Acid Treatment in Patients with Non-Alcoholic Steatohepatitis: A Secondary Analysis of the Regenerate Study Across Fibrosis Stages. (February 2020) Authors: Sanyal, A.J.; Ratziu, V.; Loomba, R.; Rinella, M.; Anstee, Q.M.; Goodman, Z.; Bedossa, P.; Khalili, M.; Boursier, J.; Stinton, L.; Marchesini, G.; Allison, M.; George, J.; Arkkila, P.; Bugianesi, E.; Zaru, L.; MacConell, L.; Shringarpure, R. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.05.5 OBETICHOLIC ACID TREATMENT IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A SECONDARY ANALYSIS OF THE REGENERATE STUDY ACROSS FIBROSIS STAGES. (1st October 2020) Authors: Sanyal, A.J.; Ratziu, V.; Loomba, R.; Rinella, M.; Anstee, Q.M.; Goodman, Z.; Bedossa, P.; Khalili, M.; Boursier, J.; Stinton, L.; Marchesini, G.; Allison, M.; George, J.; Arkkila, P.; Bugianesi, E.; Zaru, L.; Macconell, L.; Shringarpure, R.; Younossi, Z. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PC.01.9 EVALUATION OF OBETICHOLIC ACID EFFICACY IN PATIENTS WITH NASH WHO WERE MONITORED USING NONINVASIVE TESTS: A POST HOC ANALYSIS OF THE REGENERATE TRIAL. (September 2021) Authors: Vespasiani Gentilucci, U.; Alkhouri, N.; Sanyal, A.J.; Ratziu, V.; Rinella, M.; Loomba, R.; Dufour, J.; Granston, T.; Zhou, H.; Bedossa, P.; Goodman, Z.; Younossi, Z.; Anstee, Q.M.; Von Roenn, N.; Harrison, S. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. T06.01.12 OBETICHOLIC ACID (OCA) IMPROVES NON-INVASIVE MARKERS OF FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH): A SECONDARY ANALYSIS OF THE PHASE 3 REGENERATE STUDY. (1st October 2020) Authors: Anstee, Q.M.; Harrison, S.; Sanyal, A.J.; Ratziu, V.; Rinella, M.; Younossi, Z.Y.; Boursier, J.; Francque, S.; Geerts, A.; Petta, S.; Bugianesi, E.; Romero-Gomez, M.; Schattenberg, J.M.; Sarkar, S.; Bonacini, M.; Yataco, M.; Porayko, M.; Siddique, A.; Dufour, J.; Ferro, T. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗